Cogent Biosciences (COGT) Cash & Current Investments (2017 - 2021)
Historic Cash & Current Investments for Cogent Biosciences (COGT) over the last 5 years, with Q3 2021 value amounting to $202.9 million.
- Cogent Biosciences' Cash & Current Investments rose 5676.71% to $202.9 million in Q3 2021 from the same period last year, while for Sep 2021 it was $202.9 million, marking a year-over-year increase of 5676.71%. This contributed to the annual value of $242.2 million for FY2020, which is 54715.16% up from last year.
- As of Q3 2021, Cogent Biosciences' Cash & Current Investments stood at $202.9 million, which was up 5676.71% from $218.1 million recorded in Q2 2021.
- In the past 5 years, Cogent Biosciences' Cash & Current Investments ranged from a high of $242.2 million in Q4 2020 and a low of $21.3 million during Q2 2020
- In the last 5 years, Cogent Biosciences' Cash & Current Investments had a median value of $82.5 million in 2018 and averaged $107.1 million.
- As far as peak fluctuations go, Cogent Biosciences' Cash & Current Investments plummeted by 6187.75% in 2019, and later skyrocketed by 92195.2% in 2021.
- Cogent Biosciences' Cash & Current Investments (Quarter) stood at $49.6 million in 2017, then soared by 97.56% to $97.9 million in 2018, then crashed by 61.79% to $37.4 million in 2019, then skyrocketed by 547.15% to $242.2 million in 2020, then decreased by 16.23% to $202.9 million in 2021.
- Its last three reported values are $202.9 million in Q3 2021, $218.1 million for Q2 2021, and $230.7 million during Q1 2021.